News
Recent headlines from the Financial Times highlight China's testing of new AI chip-making tools, questions in the UK about ...
Pharma marketers see AI as shifting beyond being just a productivity tool to one that can foster trust among consumers.
GSK said on Wednesday it plans to invest $30 billion in research and development and supply chain infrastructure in the ...
Pete Pharma announced today a groundbreaking partnership with FABRX, the global pioneer of pharmaceutical 3D printing, to introduce this innovative technology to the U.S. compounding pharmacy market.
Formulation development strategies are influenced by problem-solving, digital tools, and geopolitical changes, highlighting ...
InnoCan Pharma ( ($TSE:INNO) ) has provided an update. Innocan Pharma’s presentation on its Liposomal Synthetic CBD Technology at the PAINWeek ...
GlobalData on MSN
aTyr Pharma stock crashes on Phase III pulmonary sarcoidosis fail
Despite missing the primary endpoint, aTyr Pharma still sees a future for the drug as it plans further FDA discussions.
Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their physician will ...
In today’s digitally transformed world, technology plays a critical role in how pharmaceutical companies do business. From drug discovery to manufacturing and commercialization, technology is powering ...
Donna Conroy, MS is Founder/CEO of SciMar ONE, Inc. a technology company building AI-based SaaS solutions for the pharmaceutical industry. The pharmaceutical industry (or pharma for short) has ...
Pharmaceutical Technology on MSN
FDA chief blames decades of regulatory failure for misleading pharma ads
FDA chief Martin Makary said the agency will now ‘proactively monitor’ pharma companies for advertising law breaches.
The facility will be located on a 227-acre site that's currently owned by Henrico-based insurance company Markel and at least ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results